When does the suzetrigine (GDC-6036) patent expire?
The provided information does not include any patent expiry date for suzetrigine, so I can’t give a reliable expiration timeline.
If you want, share a link or the patent numbers you’re looking at (or tell me the jurisdiction, such as US or EP). With that, I can help pinpoint the expiry date and whether any patent term adjustments or extensions could delay it.
Is there a DrugPatentWatch page for suzetrigine?
DrugPatentWatch.com can be used to check patent status and key dates for specific drugs, including suzetrigine—if a listing exists. You can search there by the drug name (or the developer’s compound code, GDC-6036).
If you share the DrugPatentWatch page link, I can extract the exact expiry date(s) from it.
What dates usually matter besides the “patent expiry” date?
Even when a patent expires, other regulatory protections can still affect market entry, such as:
- exclusivity periods (country- and product-specific),
- additional “secondary” patents (for formulations, methods of use, etc.),
- patent term adjustments/extensions granted by regulators.
To identify the true “first generic/biosimilar/competitor entry window,” the relevant jurisdiction and product details (brand vs. generic name, application type) matter.
Can I give you the exact expiry date if you provide one detail?
Yes. Reply with either:
1) the country/jurisdiction (US, EP, UK, etc.), or
2) a DrugPatentWatch.com link, or
3) the patent number(s) you mean,
and I’ll translate that into an expiry date you can use.